COVID-19 vaccine

New vaccine at the door: Moderna begins antidote trials against omicron variant

Moderna es la tercera farmacéutica en anunciar pruebas de una vacuna contra la variante ómicron esta semana.

Moderna is the third drugmaker to announce trials of a vaccine against the omicron variant this week. Photo: Maddie Meyer/Getty Images modern announced this Wednesday that it began the second-phase clinical trials of its vaccine for fight the omicron variant of covid-19. The Massachusetts-based pharmaceutical company indicated that this phase of the study will include …

New vaccine at the door: Moderna begins antidote trials against omicron variant Read More »

WHO Says Data Point to Vaccines Offering Six-Month Immunity

OMS dice que los datos apuntan a que las vacunas ofrecen inmunidad de seis meses

Photo: PHILIPPE LOPEZ / AFP / Getty Images The World Health Organization (WHO) said that the review of the information and scientific data related to the duration of immunity offered by vaccines against covid-19 indicates that it lasts up to six months after receiving the second vaccination (or the single dose in the case of …

WHO Says Data Point to Vaccines Offering Six-Month Immunity Read More »

COVID: FDA Authorizes Booster for Pfizer and Moderna Vaccines for All Adults

La FDA aprueba la dosis de refuerzo de Pfizer y Moderna contra el covid-19 para todos los adultos.

The FDA approves the booster dose of Pfizer and Moderna against COVID-19 for all adults. Photo: Justin Sullivan / Getty Images The Federal Food and Drug Administration (FDA) Authorized Boosters of Pfizer / BioNTech and Moderna Covid / 19 Vaccines for All Adults. Previously, they had given the green light to the booster dose in …

COVID: FDA Authorizes Booster for Pfizer and Moderna Vaccines for All Adults Read More »

What you should know before vaccinating your children against COVID-19

Algunos padres han expresado sus dudas sobre vacunar a sus hijos contra el COVID-19.

Some parents have expressed doubts about vaccinating their children against COVID-19. Photo: PATRICK T. FALLON / AFP / Getty Images The Centers for Disease Control and Prevention (CDC) authorized the children ages 5 to 11 receive pediatric doses of the vaccine from Pfizer and BioNTech to prevent COVID-19. Although this gave many parents a sigh …

What you should know before vaccinating your children against COVID-19 Read More »

CDC indicates that immunosuppressed may require a fourth dose of vaccine against covid-19

Aplicación de vacunas contra el covid-19 en California.

Application of vaccines against covid-19 in California. Photo: FREDERIC J. BROWN / AFP / Getty Images After last August the Centers for Disease Control and Prevention (CDC) will authorize a third dose of the covid-19 vaccine to certain people 18 years of age and older who are immunosuppressed, in October they gave the green light …

CDC indicates that immunosuppressed may require a fourth dose of vaccine against covid-19 Read More »

Will FDA Authorize Combination Brands in Covid-19 Booster Vaccine?

Vacuna de Johnson & Johnson contra covid-19.

Johnson & Johnson vaccine against covid-19. Photo: Joe Raedle / Getty Images Although the use of the same vaccine will be prioritized, it will be possible to combine the brands when receiving the booster dose. Press reports anticipate that this could be the announcement of the Food and Drug Administration (FDA) midweek, and they do …

Will FDA Authorize Combination Brands in Covid-19 Booster Vaccine? Read More »

What vaccines are not authorized to enter the United States?

La vacuna rusa Sputnik V, no autorizada por el gobierno de Estados Unidos.

The United States will welcome foreign travelers from November 8, as long as they have complete vaccination schedule against him covid-19 and have received any of the authorized drugs. Travelers who have received the following vaccinations they will not be able to enter the United States, even if they have a complete schema: Sputnik V. …

What vaccines are not authorized to enter the United States? Read More »

Russian Sputnik V vaccine is 91.6% effective, says The Lancet medical journal

Vacuna rusa Sputnik V tiene una eficacia del 91.6%, asegura revista médica The Lancet

An interim analysis of data from the phase III trial of Russia’s covid-19 vaccine (Sputnik V) suggests that a two-dose regimen is 91.6% effective against symptomatic disease; a protection that in people over 60 is very similar and rises to 91.8%. Preliminary results, published in “The Lancet,” are based on analysis of data from nearly …

Russian Sputnik V vaccine is 91.6% effective, says The Lancet medical journal Read More »

Coronavirus vaccine: 4 unknowns that remain to be answered

Vacuna contra el coronavirus: 4 incógnitas que quedan por responder

A race against time. This is how the mobilization to vaccinate the world population against the coronavirus and restore normality as quickly as possible could be described. Until last January 23, they were already more than 60 million people who have received some dose of the vaccines against the pathogen. But as more countries accelerate …

Coronavirus vaccine: 4 unknowns that remain to be answered Read More »